ONKURE THERAPEUTICS
OnKure is a biotechnology company that commercializes a new cancer therapy based on novel, less toxic kinase inhibitor drugs. The company is engaged in the discovery and development of epigenetic therapies for the treatment of cancer that includes selective inhibitors of histone deacetylases. In pre-clinical models of both hematological and solid tumor cancers, their lead candidate, OKI-179, significantly and safely reduces the growth rate of tumors when dosed by itself or in combination with ot... her targeted therapies. OnKure advances the HDAC3 selective inhibitor OKI-422 into pre-clinical toxicology studies. The company's drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenvironment such that checkpoint inhibition is optimized.
ONKURE THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2011-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.onkuretherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
720-307-2892
Email Addresses:
[email protected]
Total Funding:
67.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Immusoft
Immusoft, a biotechnology company, commercializes technologies that program the human immune system by modifying the DNA in related cells.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Tyra Biosciences
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Surveyor Capital
Surveyor Capital investment in Series B - OnKure Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series B - OnKure Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - OnKure Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - OnKure Therapeutics
Acorn Bioventures
Acorn Bioventures investment in Series B - OnKure Therapeutics
Delian Capital
Delian Capital investment in Series A - OnKure Therapeutics
OnKure management
OnKure management investment in Series A - OnKure Therapeutics
Key Employee Changes
Official Site Inspections
http://www.onkuretherapeutics.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.58 K
- Host name: wpx.net
- IP address: 194.1.147.46
- Location: Chicago United States
- Latitude: 41.8719
- Longitude: -87.6589
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60607
More informations about "OnKure Therapeutics"
OnKure Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 720-307-2892 OnKure is a biotechnology company that commercializes a new cancer therapy based on novel, less toxic โฆSee details»
OnKure Therapeutics - LinkedIn
OnKure Therapeutics | 3,237 followers on LinkedIn. Discovering and developing best in class precision medicines for the treatment of cancer | OnKure is committed to the discovery and development ...See details»
OnKure Therapeutics - PitchBook
OnKure Therapeutics General Information Description. OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and โฆSee details»
OnKure Therapeutics (OKUR) Company Profile & Description
6707 Winchester Circle, Suite 400 Boulder, Colorado 80301 United StatesSee details»
Onkure Therapeutics Inc, OKUR:NMQ profile - FT.com - Financial โฆ
1 day ago OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers โฆSee details»
Onkure Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Onkure Therapeutics, Inc. of Boulder, CO. Get the latest business insights from Dun & Bradstreet.See details»
OnKure Company Profile - Office Locations, Competitors, Revenue โฆ
OnKure $8.09 m in total funding,. See insights on OnKure including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
OnKure - Overview, News & Similar companies | ZoomInfo.com
In this position, Dr. Hartley will lead the companyโs research organization. Jul 25, 2024. www.globenewswire.com . OnKure names Rogan Nunn as general counsel - BizWest ... (720) โฆSee details»
OnKure Therapeutics - About Our Company
OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer that are underserved by available therapies.See details»
OnKure Therapeutics Company Overview, Contact Details
Mar 4, 2021 Jun 19, 2024 | onkuretherapeutics.com Reneopharma merged with OnKure Therapeutics, Inc. on May 20th '24. Reneo Pharmaceuticals (NASDAQ:RPHM) to merge with โฆSee details»
OnKure Therapeutics Overview | SignalHire Company Profile
Organization Website: onkuretherapeutics.com : Phone Number: 720 307-2892: OnKure Therapeutics industries Pharma, Pharmaceuticals, BiotechnologySee details»
OnKure Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Nov 10, 2024 Explore OnKure Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 12 clinical trials, 83 news, and 16 literature, Disease Domain ...See details»
OnKure Therapeutics - Company Profile & Staff Directory
Https://onkuretherapeutics.com. Employees: 11-50 employees View all OnKure Therapeutics employees. Industry: Pharmaceuticals Location: 6707 Winchester Circle; Suite 400, Boulder, โฆSee details»
OnKure Therapeutics Leadership Team
At Pfizer Boulder and the legacy Array BioPharma Inc. organization, Dr. Wong oversaw nonclinical and translational in vivo studies to support the small molecule oncology drug โฆSee details»
OnKure Announces Closing of Merger with Reneo Pharmaceuticals โฆ
Oct 4, 2024 -- OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kฮฑ), initially in breast cancer -- On track to โฆSee details»
News Releases - OnKure Therapeutics
Mar 4, 2025 โ PIKture-01 trial update including additional PK data, mature single agent and initial combination data expected in the second half of 2025; reported encouraging preliminary โฆSee details»
OnKure Therapeutics - Our Success is Written in Our DNA
The OnKure team is comprised of proven drug discovery and development scientists who are combining their cancer biology, medicinal chemistry and development expertise to create a โฆSee details»
Release Details - investors.onkuretherapeutics.com
BOULDER, ColoradoโAugust 3, 2021 โ OnKure, Inc., a clinical-stage biopharmaceutical company pioneering a novel Class-1 selective histone deacetylase inhibitor for the treatment โฆSee details»
OnKure Expands Executive Team with the Addition of Chief โฆ
BOULDER, ColoradoโAugust 3, 2021 โ OnKure, Inc., a clinical-stage biopharmaceutical company pioneering a novel Class-1 selective histone deacetylase inhibitor for the treatment โฆSee details»
U.S. FDA Grants Full Approval of VITRAKVI® (larotrectinib) for โฆ
WHIPPANY, N.J., April 10, 2025 โ Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class โฆSee details»